ESPR — Esperion Therapeutics Share News
0.000.00%
Last trade - 00:00- $822.04m
- $1.21bn
- $403.14m
Brief: Esperion Receives Five Year Patent Extension for Bempedoic Acid, Contained in NEXLETOL and NEXLIZET
U.S. STOCKS ON THE MOVE-Henry Schein, Dave, Delek
U.S. STOCKS ON THE MOVE-Vanda Pharmaceuticals, FMC, Duke Energy
Esperion Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
U.S. STOCKS ON THE MOVE-Tesla, Instacart, Boeing
Esperion Therapeutics surges on upbeat Q1 results
Brief: Esperion Therapeutics Q1 Basic EPS USD 0.36
Esperion Therapeutics Inc expected to post earnings of 5 cents a share - Earnings Preview
Esperion Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Brief: Esperion Therapeutics Q4 Basic EPS USD -0.5
Esperion Therapeutics Inc expected to post a loss of 48 cents a share - Earnings Preview
Brief: Esperion Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-SciSparc, Teekay Tankers
U.S. STOCKS ON THE MOVE-Intuitive Surgical, Ally Financial, Modular Medical
U.S. STOCKS ON THE MOVE-IBM, Wayfair, Netflix
U.S. STOCKS ON THE MOVE-Super Micro Computer, Coherus, Travelers Companies
Esperion Therapeutics slides on deep-discounted stock offering
Brief: Esperion Announces Pricing Of $85.1 Million Public Offering Of Common Stock
Brief: Esperion Announces Proposed Public Offering Of Common Stock